OMER FY 2010 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$813M

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+45.8% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$30M-1430.2% margin

Net Income

-$29M-1389.6% margin

EPS (Diluted)

$-1.37

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$46M

Total Liabilities

$25M

Stockholders' Equity

$20M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+45.8%
Gross Profit	$2M	$1M	+45.8%
Operating Income	-$30M	-$21M	-45.0%
Net Income	-$29M	-$21M	-38.7%